CDx Diagnostics
Highly Engaged Employees
Business Services · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4 Executive Blvd Ste 101, Suffern, New Y...Phone Number
(845) 738-7512Website
www.cdxdiagnostics.comRevenue
$21.2 MillionIndustry
About CDx Diagnostics
CDx Diagnostics' mission of Empowering Physicians with Innovative Technology to Prevent Esophageal Cancer, One Patient at a Time is accomplished through a proprietary diagnostic platform. This combination of technology synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous changes earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care. Routine clinical use of CDx testing has detected thousands of cancers and precancerous conditions that otherwise would have been missed in time for effective treatment. CDx Diagnostics is a Galen Partners portfolio company.Explore more
SIC Code 87,873NAICS Code 54,541Show moreCDx Diagnostics Org Chart
Compare Similar Companies to CDx Diagnostics
Compare insights from companies similar to CDx Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CDx Diagnostics
$21.2M
51-200
Private
$13.5M
2010
EY
Edward YomSenior Vice President, Chief Technology Officer
CDx Diagnostics Tech Stack
A closer look at the technologies used by CDx Diagnostics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CDx Diagnostics
Sign Up For FreeTo access detailed company insights
CDx Diagnostics' mission of Empowering Physicians with Innovative Technology to Prevent Esophageal Cancer, One Patient at a Time is accomplished through a proprietary diagnostic platform. This combination of technology synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous... Read More